HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 264 | 300 | 88.0% | |
| HF004 | 2020 | 254 | 291 | 87.3% | |
| HF006 | 2021 | 301 | 340 | 88.5% | |
| HF006 | 2022 | 331 | 347 | 95.4% | |
| HF006 | 2023 | 430 | 434 | 99.1% |
